TRPA1 and lung adenocarcinoma: In agreement with this hypothesis, TRPA1 can physically associate with the fibroblast growth factor receptor 2 (FGFR2) via its NH2-terminal ARD and thereby stimulate lung adenocarcinoma (LUAD) progression and metastatic spreading in a Ca2+-independent manner [99].